title: Targeting obesity, insulin resistance and Type 2 diabetes with immunotherapy: the challenges ahead.
authors.affiliation: Department of Internal Medicine & Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. masakazu731079@yahoo.co.jp.
authors.forename: Masakazu
authors.initials: M
authors.lastname: Fujii
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Sonoda
authors.forename: Ryoichi
authors.initials: R
authors.lastname: Takayanagi
authors.forename: Tosyoshi
authors.initials: T
authors.lastname: Inoguchi
mesh_terms: D000069594:Abatacept; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000276:immunology / Q000628:therapy*; D004195:Disease Models, Animal; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D007167:Immunotherapy / Q000639:trends*; D007333:Insulin Resistance / Q000276:immunology; D051379:Mice; D058990:Molecular Targeted Therapy; D009765:Obesity / Q000276:immunology / Q000628:therapy*
chemical_list: D018796:Immunoconjugates; D000069594:Abatacept